PT  - JOURNAL ARTICLE
ED  - , 
TI  - The PROTAC DT2216 Targets Cancer by Promoting BCL-X<sub>L</sub> Degradation
AID  - 10.1158/2159-8290.CD-RW2019-185
DP  - 2019 Dec 13
TA  - Cancer Discovery
4099  - http://cancerdiscovery.aacrjournals.org/content/early/2019/12/13/2159-8290.CD-RW2019-185.short
4100  - http://cancerdiscovery.aacrjournals.org/content/early/2019/12/13/2159-8290.CD-RW2019-185.full
AB  - DT2216, a proteolysis-targeting chimera (PROTAC), effectively targets BCL-XLfor degradation.